Its main property is its ability to help prevent obesity and changes in the liver. At this stage, the scientists got what they wanted in the mice.
The drug, called CPACC, limits the supply of magnesium to the mitochondria, the energy centers of cells, and may reduce the risk of cardiometabolic diseases such as heart attack and stroke, as well as the incidence of liver cancer.
The novelty proved to be a working option in preventing obesity in mice fed a diet high in sugar and fat. The drug is expected to help combat the global obesity epidemic and its associated health problems.
Recall that according to the latest WHO data, obesity in the world has tripled since 1975. More than 1.9 billion adults are considered overweight today.
Source: Ferra
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
